Anuh Pharma Ltd. — Board/Management Information 2023

==> picture [264 x 160] intentionally omitted <==

Date: 13[th] December, 2023

To,

The Manager (Listing) BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001

Ref: Scrip Code No. 506260

Sub: Intimation under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 – Change in Director.

Dear Sir/Madam,

Pursuant to Regulation 30(2) read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that based on recommendation of Nomination Remuneration Committee and Board of Directors at their meeting held on 10[th] November, 2023, the members at their Postal Ballot held on 10[th] December, 2023 had approved, the appointment/ reappointment of below mentioned Directors:

1. To continue the Directorship of Mr. Bipin N. Shah, (DIN: 00083244) as a Non-Executive.

Re-appointment of Mr. Bipin N. Shah, (DIN: 00083244) as a NonExecutive, who will be attaining the age of 75 years to continue as a Director of the Company on and after March 07, 2024 till the expiry of his term, under Regulation 17(1A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

==> picture [451 x 63] intentionally omitted <==

==> picture [264 x 160] intentionally omitted <==

2. Re-appointment of Dr. Mita Dixit (DIN 08198165) as a Non-Executive, Independent Director.

Re-appointment of Dr. Mita Dixit (DIN 08198165) as a Non-Executive, Independent Director for a Second term of 5 (Five) consecutive years effective from 1st April, 2024 to 31st March, 2029;

3. Re-appointment of Mr. H. T. Patel (DIN 07342390) as a NonExecutive, Independent Director.

Re-appointment of Mr. H. T. Patel (DIN 07342390) as a Non-Executive, Independent Director for a Second term of 5 (Five) consecutive years effective from May 22[nd] , 2024 to 21[st] May, 2029;

4. Appointment of Mr. Pradeep Thakur (DIN: 00685992) as an Additional Director (Non-Executive, Independent Director).

Appointment of Mr. Pradeep Thakur (DIN: 00685992) as an Additional Director (Non-Executive, Independent Director) of the Company for a First term of 5 (Five) consecutive years effective from 1st April, 2024 to 31st March, 2029;

5. Appointment of Mr. Siddharth Shah (DIN: 00004958) as an Additional Director (Non-Executive, Independent Director).

Appointment of Mr. Siddharth Shah (DIN: 00004958) as an Additional Director (Non-Executive, Independent Director) of the Company for a First term of 5 (Five) consecutive years effective from 1st April, 2024 to 31st March, 2029;

Further, as per the requirement of the Circular No. List/Comp/14/2018-19 dated 20th June, 2018 issued by BSE on the subject of enforcement of SEBI Orders regarding appointment of Directors by listed companies we hereby affirm that the Director being appointed is not debarred from holding the office of director by virtue of any order of SEBI or any other such authority.

==> picture [451 x 63] intentionally omitted <==

==> picture [264 x 160] intentionally omitted <==

The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. ClR/CFD/CMD/4/2015 dated 9th September, 2015 are given in the enclosed Annexure-1.

The above is for your information and records please.

Thanking you,

Yours faithfully,

For Anuh Pharma Ltd.

HEMANT Digitally signed by HEMANT KISAN AUTI KISAN AUTI Date: 2023.12.13 14:52:46 +05'30'

Hemant Auti

Company Secretary & Compliance Officer

==> picture [451 x 63] intentionally omitted <==

==> picture [264 x 160] intentionally omitted <==

ANNEXURE-1

BRIEF PROFILE OF MR. BIPIN SHAH IS AS FOLLOWS:

Mr. Bipin Shah is a Chemical Engineer by qualification. He is the vice Chairman of Anuh Pharma Ltd., a leading bulk drug manufacturing company and is also Director / Partner in other SK Group of Companies / Firms, who are in the pharmaceutical industry since last 90 years and he is responsible for distribution, C & F and Mother Depot operations of the group. He has a vast experience of nearly 50 years in the pharmaceutical field and is widely travelled. His specific area of interest has been marketing and management.

He is currently the President of Thane Belapur Industries Association and he is a Managing Committee Member of Indian Merchant Chambers, Mumbai.

The Board considers that the continued association of Mr. Bipin N. Shah, aged 74 years, would be of immense benefit to the Company and is desirable to continue to avail the services of Mr. Bipin N. Shah as a Director. Mr. Bipin N. Shah has a rich experience of about 5 decades in the Pharma Industry and is involved with the SK Group’s various business activities like Pharmaceutical formulation / API manufacturing, exports, R&D etc. Accordingly, pursuant to the Amended Listing Regulations 2018.

BRIEF PROFILE OF DR. MITA C. DIXIT IS AS FOLLOWS:

Dr. Mita C. Dixit is a Chemical Engineer, Masters in Marketing Management, and PhD from BITS Pilani University. She is the first Indian to do a doctoral research in ‘Conflict and Splits in Indian Family Businesses.’ She is a Certified Management Consultant and a Corporate Director. She is a member of the Family Enterprise Research Consortium (USA), and a member of the Editorial Board, Journal of Amity Business School, India.

==> picture [451 x 63] intentionally omitted <==

==> picture [264 x 160] intentionally omitted <==

During the initial phase of her career, Mita worked with prominent corporates (Indian Express, Garwares, Piramal group) in marketing, branding, and product management functions. She was the Head - Research and Consultancy for the Centre for Family Managed Business at SPJIMR, Mumbai. As a Visiting faculty, she is associated with renowned management institutes offering family business programmes.

BRIEF PROFILE OF MR. H. T. PATEL IS AS FOLLOWS:

Mr. H. T. Patel, aged 68 years, is B Sc., ANSI (Sugar Technology), MBA by qualification. His DIN is 07342390. He has over 4 decades of varied experience, mainly in the pharmaceutical industry. He served as President API Business – Zydus Cadila in his last job. Before that he worked in Alembic Limited for 25 long years. He has discharged responsibilities in senior positions in reputed business groups with international operations. He is also a Director of Lewens Labs Private Limited Bharuch and Commercial Cooperative Bank Limited Vadodara.

He is on the Board of Management of Charusat University, Changa, Dist. Anand. He is a President and Managing Trustee of Yuvalay Charitable Trust, Vadodara and involved in many other social activities.

BRIEF PROFILE OF MR. PRADEEP THAKUR IS AS FOLLOWS:

Mr. Pradeep Thakur is a Post Graduate in Chemistry from Mumbai University and has Diploma in Export Management. He has studied “Masters in Administrative Management” at Jamnalal Bajaj Institute of Management studies, Mumbai. He has more than 30 years of working experience in Chemical and Pharmaceutical Industry in various functions like Process Development, Quality control, Quality Assurance, Business Development and General Administration. He has in the past worked with Bayer India, Anamed Instruments, Cipla Ltd, Dr. Reddy’s Labs, Schweizerhall India and Aceto Pharma India Private Limited in various positions. His last assignment was with Aceto Pharma India Pvt. Limited as a Managing Director.

==> picture [451 x 63] intentionally omitted <==

==> picture [264 x 160] intentionally omitted <==

BRIEF PROFILE OF MR. SIDDHARTH SHAH IS AS FOLLOWS:

Mr. Siddharth Shah holds a degree in Civil Engineering, Master in Business Administration and a Diploma in Securities Law. He has been on the Board of Directors of various Market Infrastructure Companies such as Bombay Stock Exchange (BSE), Central Depositories Services Ltd. (CDSL) and BOI Shareholding Ltd (a JV between BSE and Bank of India).

He has a vast experience of nearly 33 years in the financial markets and numerous technology based platforms. He was instrumental in many landmark projects like Online Trading platform of BSE, Demutualization and Corporatization of BSE, Listing of BSE, among others.

He held the leadership role as Chairman of BSE Brokers Forum (an Industry body of more than 1,000 brokers).

He is currently the CEO of his 3rd generation family run brokerage house dealing in various investment verticals.

==> picture [451 x 63] intentionally omitted <==